Skip to main content
. 2017 Nov 14;8(64):108020–108030. doi: 10.18632/oncotarget.22445

Table 3. Average numbers of somatic non-synonymous mutations and mutant genes among 578 cancer-relevant genes investigated.

Average no. of non-synonymous mutations p-value Average no. of mutant genes (any frequency for mutant alleles) p-value Average no. of mutant genes (frequency ≥ 25 % for mutant alleles) p-value
Colorectal adenoma (n = 11) 1442 370 78
CIMP-negative (n = 9) 1433 ns 355 ns 58 ns (0.099)
CIMP-positive (n = 2) 1485 440 170
Colorectal carcinoma (n = 18) 1124 361 97
CIMP-negative (n = 9) 1050 ns 346 ns 77 ns
CIMP-positive (n = 9) 1198 375 118
Colorectal tumors combined (n = 29) 1245 364 90
CIMP-negative (n = 18) 1242 ns 351 ns 67 ns (0.076)
CIMP-positive (n = 11) 1250 387 128
Ovarian carcinoma (n = 16)* 657 162 30
CIMP-negative (n = 12) 252 0.014 99 0.014 25 0.030
CIMP-positive (n = 3) 2494 464 58
Colorectal and ovarian tumors combined (n = 45) * 954 287 70
CIMP-negative (n = 30) 846 0.011 250 0.019 50 0.004
CIMP-positive (n = 14) 1517 403 113

*Includes one ovarian carcinoma with CIMP status unknown.

p-values were calculated by Mann-Whitney U test (ns, non-significant).

Case-by-case data on CIMP status vs. no. of mutations or mutant genes are shown in Supplementary Table 2.